
⸺ Synova Research
Semax supplied as a ready-to-use nasal spray solution, ≥99% purity. Intranasal presentation for preclinical neuropeptide research.
Secure checkout via UK open banking. Free shipping on orders over £100.
Independently tested
COA on request
Next-day UK dispatch
Order before midnight
Research use only
Not for human consumption
⸺ Important
⸺ Overview
Semax is a synthetic ACTH(4-10) analogue supplied here as a pre-mixed nasal spray. The intranasal format removes the need for reconstitution and is used in preclinical research into cognition, neuroprotection and stress-response signalling.
⸺ Mechanism of Action
Semax is studied for its influence on brain-derived neurotrophic factor (BDNF) expression and monoamine signalling, pathways associated with neuronal plasticity and resilience in animal models.
⸺ Research
Rodent studies report increased BDNF expression following Semax administration.
Preclinical work explores effects on learning, memory retention and attention-related behaviour.
Animal models of ischaemic injury are used to study protective effects on neuronal tissue.
Summarised from preclinical literature for informational purposes only. Not medical or veterinary advice. Synova Research products are sold strictly for in-vitro and laboratory research.
⸺ Details

Investigational triple receptor agonist targeting GLP-1, GIP and glucagon — studied in animal models for appetite control, energy expenditure and glucose balance.

Dual GLP-1 and GIP receptor agonist studied in preclinical models for glucose regulation, insulin sensitivity and energy balance.

Synthetic analogue of the GLP-1 hormone used in research to study glucose regulation, insulin secretion and the incretin response.